Rapid Diagnostic Tests: Market Size & Forecast 2026

The global rapid diagnostic tests market reached approximately USD 10.2 billion in 2025, held in a structurally tight balance between post-pandemic normalization of infectious disease testing demand, accelerating at-home testing adoption, and a concentrated supply base facing a materials-cost reversal after two years of inventory destocking. Industry data indicates the market is growing at roughly 5.8 percent CAGR through 2032, taking the category to approximately USD 15.5 billion by the forecast year [Claight estimate: consensus range 5.0, 6.5 percent, central 5.8 percent derived from segment-weighted average of infectious disease, cardiac, and pregnancy testing CAGRs]. The dominant supply state is tight for specialized inputs, nitrocellulose membranes and conjugated antibodies, while finished-test capacity sits in moderate oversupply across lateral flow formats. > **Analyst Take.** The

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.